HOXD9 affecting glioma proliferation and invasion

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gliomas are primary brain tumors with significant morbidity and mortality.
• Understanding the molecular mechanisms driving glioma progression is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the role of the homology box D9 gene (HOXD9) in glioma.
• To determine the association between HOXD9 expression, clinical features, and patient prognosis.
• To explore the impact of HOXD9 on glioma cell proliferation and migration.

Main Methods:

• HOXD9 knockdown models were created in U251 and U87-MG glioma cell lines.
• Cell proliferation and migration assays (CCK8, plate cloning, Transwell) were performed.
• TCGA database analysis was used to assess HOXD9 mRNA expression and survival outcomes.
• Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO), and KEGG pathway analyses were conducted.
• Immune cell infiltration analysis was performed.

Main Results:

• Knockdown of HOXD9 significantly inhibited glioma cell proliferation and migration in vitro.
• HOXD9 expression was found to be upregulated in glioma tissues.
• Higher HOXD9 expression correlated with poorer overall survival (OS) in glioma patients.
• GSEA, GO, and KEGG analyses indicated HOXD9 involvement in multiple biological processes and signaling pathways.
• HOXD9 expression was associated with the infiltration of various immune cells, suggesting an impact on the tumor immune microenvironment.

Conclusions:

• HOXD9 plays a significant role in promoting glioma cell proliferation and migration.
• Upregulated HOXD9 expression in gliomas is linked to adverse patient prognosis.
• HOXD9 represents a potential therapeutic target and a valuable biomarker for glioma management.